Albumin Administration in ESRD Patients Undergoing Paracentesis

Introduction to Albumin Administration

The American Association for the Study of Liver Diseases and the European Association for the Study of the Liver recommend administering albumin using the same volume-based guidelines as for cirrhotic patients (8 g/L for >5 L removed) in patients with ESRD on hemodialysis undergoing paracentesis, with heightened vigilance for fluid overload given the inability to clear excess volume renally 1, 2

For large-volume paracentesis (>5 L), administer 8 g of albumin per liter of ascites removed, using 20% or 25% albumin solution infused after paracentesis completion, as recommended by the European Society of Gastrointestinal Endoscopy 1, 2, 3, 4
For paracentesis <5 L, albumin replacement is generally not required in standard cases, but consider albumin at 8 g/L even for smaller volumes if the patient has acute-on-chronic liver failure or high risk of post-paracentesis acute kidney injury, according to the American College of Gastroenterology 2, 5, 6

Post-paracentesis circulatory dysfunction occurs in up to 80% of patients without volume expansion versus 18.5% with albumin, and without albumin after large-volume paracentesis, acute kidney injury develops in 21% of patients; with albumin, the rate approaches 0%, as reported by the International Society of Nephrology 1, 7
Preventing circulatory dysfunction reduces mortality and other complications in ESRD patients, as stated by the National Kidney Foundation 2, 3, 4

Monitor closely for signs of fluid overload (dyspnea, hypoxia, pulmonary edema) during and after albumin infusion, as recommended by the American Heart Association 1, 3
Consider reduced albumin dosing in select cases, although standard dosing (8 g/L) remains the guideline-recommended approach, according to the European Renal Association 2, 3, 5

Do not withhold albumin entirely due to ESRD status—the hemodynamic benefits of preventing circulatory dysfunction outweigh fluid overload risks when managed appropriately, as stated by the American College of Cardiology 1, 2
Do not use artificial plasma expanders as alternatives—most are contraindicated and albumin shows superior outcomes, according to the Society of Critical Care Medicine 3, 4, 6